Navigation Links
Boston Scientific Announces Results For Second Quarter Ended June 30, 2013
Date:7/25/2013

0.17)$(2.42)Weighted-average shares outstandingBasic

1,343.51,423.21,347.71,434.2Assuming dilution

1,358.61,423.21,347.71,434.2 

 

 

 

BOSTON SCIENTIFIC CORPORATIONCONDENSED CONSOLIDATED BALANCE SHEETS

 As ofJune 30, December 31,in millions, except share data20132012(Unaudited)ASSETSCurrent assets:Cash and cash equivalents

$

530$

207Trade accounts receivable, net

1,2781,217Inventories

842884Deferred income taxes

496433Prepaid expenses and other current assets

352281Total current assets

3,4983,022Property, plant and equipment, net

1,5241,564Goodwill

5,5535,973Other intangible assets, net

6,0266,289Other long-term assets

395306$16,996$17,154LIABILITIES AND STOCKHOLDERS' EQUITYCurrent liabilities:Current debt obligations

$

605$

4Accounts payable

251232Accrued expenses

1,3651,284Other current liabilities

256252Total current liabilities

2,4771,772Long-term debt

3,6474,252Deferred income taxes

1,7111,713Other long-term liabilities

2,5582,547Commitments and contingenciesStockholders' equityPreferred stock, $.01 par value - authorized 50,000,000shares, none issued and outstandingCommon stock, $.01 par value - authorized 2,000,000,000shares and issued 1,551,642,655 shares as of June 30,2013 and 1,542,347,188 shares as of December 31, 2012

1615Treasury stock, at cost 212,293,891 shares as of June 30, 2013and 186,635,532 shares as of December 31, 2012

(1,292)(1,092)Additional paid-in capital

16,47016,429Accumulated deficit

(8,673)(8,449)Accumulated other comprehensive income (loss), net of tax

82(33)Total stockholders' equity

6,6036,870$16,996$17,154 

 

 

 

BOSTON SCIENTIFIC CORPORATIONNON-GAA
'/>"/>

SOURCE Boston Scientific Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related biology technology :

1. American Laboratory Trading Continues Steady Growth with Expansion in Boston
2. Affordable Scrum Training in Boston,MA by Conscires Agile Practices
3. Formedix CEO Invited to Speak at OpenClinica Global Conference in Boston
4. The 2013 Bioprocessing Summit to Bring Together International Leaders to Discuss Today's Bioprocess Issues From Cell Line Selection to Manufacturing in Boston, MA
5. Verified Clinical Trials (VCT) Will Co-Present With SAFE-BioPharma At Bio-IT World April 10th In Boston, MA Exploring Identity Management In eClinical Trials
6. Boston Heart Diagnostics Awarded $450,000 in Tax Incentives from the Massachusetts Life Sciences Center
7. Local Leaders Convene in Boston to Share Industry Best Practices in Second “Business of Big Data” Summit
8. R&D, Innovation Key to Success - Research Report on Varian Medical Systems, Inc., Boston Scientific Corporation, Stryker Corporation, St. Jude Medical, Inc., and Thermo Fischer Scientific Inc.
9. Boston College researchers unique nanostructure produces novel plasmonic halos
10. Boston Scientific to Webcast Conference Call Discussing Fourth Quarter and Full Year 2012 Financial Results on January 29th
11. Shire and Boston Childrens Hospital Enter Into Broad Research Collaboration
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... Nov. 25, 2014  Roka Bioscience, Inc. (NASDAQ: ... testing solutions for the detection of foodborne pathogens, today announced ... Piper Jaffray  26 th Annual Healthcare Conference on December ... at The New York Palace in New York, ... information concerning the Company, its operations, strategies and prospects may ...
(Date:11/24/2014)... 2014 Five American winners will ... Maktoum Awards for Medical Sciences", in its 8 th ... Emirates , on 15 December 2014. ... The Carter Center which won the Hamdan Award for ... numerous programs that aim to improve health and promote ...
(Date:11/24/2014)... , Nov. 24, 2014 VolitionRx Limited ... tests for cancer and other conditions, today announced that data ... the Science for Business BioWin Day 2014, being held November ... data come from VolitionRx,s lung cancer pilot study, the samples ... Centre Hospitalier Universitaire (CHU) de Liege in Belgium ...
(Date:11/24/2014)... 2014   Veracyte, Inc. (Nasdaq: VCYT ... and chief executive officer, will present in a fireside chat ... Conference on Tuesday, December 2, 2014 at 12:30 p.m. ET ... live audio webcast and subsequent replay may be accessed by ... the website at least 15 minutes prior to the live ...
Breaking Biology Technology:Roka Bioscience to Present at the Piper Jaffray Healthcare Conference 2Five US Winners Among Recipients of Hamdan Medical Awards 2VolitionRx to Present Positive Data from Pilot Lung Cancer Study at BioWin Day 2014 2VolitionRx to Present Positive Data from Pilot Lung Cancer Study at BioWin Day 2014 3VolitionRx to Present Positive Data from Pilot Lung Cancer Study at BioWin Day 2014 4VolitionRx to Present Positive Data from Pilot Lung Cancer Study at BioWin Day 2014 5VolitionRx to Present Positive Data from Pilot Lung Cancer Study at BioWin Day 2014 6Veracyte to Present at the Piper Jaffray 26th Annual Healthcare Conference 2
... Breast Cancer Profile Represents First Molecular ... of Operable Breast Cancer, ALISO VIEJO, Calif., Jan. ... technology and services resource for,pathologists, oncologists and the pharmaceutical ... cancer test, the first molecular,test available that is applicable ...
... and Chairman of the Board ... ... care biopharmaceutical company, announced today that,Daniel Tasse has been appointed President and Chief ... CEO since,the creation of Ikaria Holdings in March 2007 and will now serve ...
... Q-MED AB to distribute Palomar products outside North ... Medical,Technologies, Inc. (Nasdaq: PMTI ), a leading ... today announced the execution,of an international distribution agreement ... Stockholm Mid Cap: QMED), a leading,biotech/medical device company ...
Cached Biology Technology:Clarient to Commercialize Novel Breast Cancer Profile 2Clarient to Commercialize Novel Breast Cancer Profile 3Clarient to Commercialize Novel Breast Cancer Profile 4Clarient to Commercialize Novel Breast Cancer Profile 5Ikaria Appoints Daniel Tasse as President and Chief Executive Officer 2Palomar and Q-MED AB Enter Into International Distribution Agreement 2Palomar and Q-MED AB Enter Into International Distribution Agreement 3Palomar and Q-MED AB Enter Into International Distribution Agreement 4Palomar and Q-MED AB Enter Into International Distribution Agreement 5Palomar and Q-MED AB Enter Into International Distribution Agreement 6
(Date:11/3/2014)... , Nov. 3, 2014  NeuroSigma ® , ... life sciences company focused on commercialization of its ... for the treatment of neurological and neuropsychiatric disorders, ... Property has issued a Notice of Allowance for ... is co-owned by NeuroSigma and the Regents of ...
(Date:11/2/2014)... Physics World , James Dacey explores the ways in ... take their innovations from the lab into the commercial ... all start-up companies as they move from prototype to ... main factors: physics-based inventions are usually far from market-ready ... be a lot more complicated than had been originally ...
(Date:11/2/2014)... fascinating to put a flashlight up to our palms ... University in St. Louis engineers are using a similar ... improve imaging of cancerous tissues and to develop potential ... Beare Distinguished Professor of Biomedical Engineering at the School ... time-reversal technology that allows researchers to better focus light ...
Breaking Biology News(10 mins):NeuroSigma Receives Notice of Allowance from the Mexican Institute of Industrial Property Covering Subcutaneous Trigeminal Nerve Stimulation (sTNS) 2NeuroSigma Receives Notice of Allowance from the Mexican Institute of Industrial Property Covering Subcutaneous Trigeminal Nerve Stimulation (sTNS) 3The 'valley of death' facing physics start-ups 2Improving imaging of cancerous tissues by reversing time 2
... in factory workers producing microwave popcorn might play an ... by people with cystic fibrosis (CF), according to a ... Katrine Whiteson. The molecule, known as 2,3-butanedione or diacetyl, ... than in healthy ones. CF patients experience day-to-day ...
... have long known that people with autoimmune diseases, such ... are at greater risk of developing schizophrenia. ... majority of the Danish population shows that the development ... an increased risk of contracting autoimmune diseases, especially if ...
... COLUMBUS, Ohio Chronic stress that produces inflammation and anxiety ... prolonged fight, causing the animals to have an excessive reaction ... After the mice recovered from the effects of chronic ... them to a chronically stressed state in biological and behavioral ...
Cached Biology News:Is a 'buttery' molecule behind cystic fibrosis flare-ups? 2Is a 'buttery' molecule behind cystic fibrosis flare-ups? 3Schizophrenics are at greater risk of getting diseases 2Schizophrenics are at greater risk of getting diseases 3Study in mice raises question: Could PTSD involve immune response to stress? 2Study in mice raises question: Could PTSD involve immune response to stress? 3Study in mice raises question: Could PTSD involve immune response to stress? 4
... Digital shaking water bath, with a comprehensive ... and shaking water baths with seamless, splash-water ... The bright MULTI-DISPLAY (LED) indicating up to ... the lab. Advanced MICROPROCESSOR technology with PID ...
... an aqueous solution that contains a purified ... in a MOPS buffer (3-(N-Morpholino) propanesulfonic acid), ... contains a combination of 0.02% methylisothiazolone, 0.02% ... and Haas Company) as a preservative. ...
Request Info...
... Life Science FLA-7000 excels at fluorescent and ... documentation. It features four easy-to-access filters (filters ... filter for Imaging Plates) for upgrading flexibility. ... choice of four kinds of excitation laser ...
Biology Products: